| Year |
Citation |
Score |
| 2016 |
Yang SW, Ping YF, Jiang YX, Luo X, Zhang X, Bian XW, Yu PW. ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells. Oncotarget. PMID 27276686 DOI: 10.18632/oncotarget.9827 |
0.362 |
|
| 2016 |
Huang GH, Xu QF, Cui YH, Li N, Bian XW, Lv SQ. Medulloblastoma stem cells: Promising targets in medulloblastoma therapy. Cancer Science. 107: 583-9. PMID 27171351 DOI: 10.1111/cas.12925 |
0.316 |
|
| 2016 |
Liu JJ, Liu JY, Chen J, Wu YX, Yan P, Ji CD, Wang YX, Xiang DF, Zhang X, Zhang P, Cui YH, Wang JM, Bian XW, Qian F. Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients. Cancer Letters. PMID 27033455 DOI: 10.1016/j.canlet.2016.03.035 |
0.335 |
|
| 2016 |
Guo ZJ, Yang L, Qian F, Wang YX, Yu X, Ji CD, Cui W, Xiang DF, Zhang X, Zhang P, Wang JM, Cui YH, Bian XW. Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer. Oncotarget. PMID 27007162 DOI: 10.18632/oncotarget.8236 |
0.331 |
|
| 2016 |
Duan JJ, Cai J, Guo YF, Bian XW, Yu SC. ALDH1A3, a metabolic target for cancer diagnosis and therapy. International Journal of Cancer. PMID 26991532 DOI: 10.1002/ijc.30091 |
0.303 |
|
| 2015 |
Cheng L, Xia Z, Bian X, Li G, Hu J, Cao Y, Wang Q, Qian X. Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma. Oncotargets and Therapy. 8: 3185-3192. PMID 26586952 DOI: 10.2147/OTT.S82453 |
0.316 |
|
| 2015 |
Wang J, Lei ZJ, Guo Y, Wang T, Qin ZY, Xiao HL, Fan LL, Chen DF, Bian XW, Liu J, Wang B. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells. Oncotarget. PMID 26497997 DOI: 10.18632/oncotarget.5635 |
0.309 |
|
| Show low-probability matches. |